Beta-Asarone Attenuates Neuronal Apoptosis Induced by Beta Amyloid in Rat Hippocampus
-
- LIU Jicheng
- The Institute of Medicine, Qiqihar Medical University
-
- LI Chengchong
- The Institute of Medicine, Qiqihar Medical University
-
- XING Guihua
- The Institute of Medicine, Qiqihar Medical University
-
- ZHOU Li
- The Institute of Medicine, Qiqihar Medical University
-
- DONG Miaoxian
- The Institute of Medicine, Qiqihar Medical University
-
- GENG Yutao
- The Institute of Medicine, Qiqihar Medical University
-
- LI Xueyan
- The Institute of Medicine, Qiqihar Medical University
-
- LI Jiaming
- The Institute of Medicine, Qiqihar Medical University
-
- WANG Gang
- The Institute of Medicine, Qiqihar Medical University
-
- ZOU Dejia
- The Institute of Medicine, Qiqihar Medical University
-
- NIU Yingcai
- The Institute of Medicine, Qiqihar Medical University
Search this article
Abstract
Neurodegenerative disorders, such as Alzheimer's disease (AD), is associated with the loss of neuronal cells, and it has been suggested that apoptosis is a crucial pathway in neuronal loss in AD patients. Recent evidence suggests that amyloid beta peptide (Aβ) induces neuronal apoptosis in the brain and in primary neuronal cultures. In this study, we investigated the impact of β-asarone against the apoptosis induced by Aβ in rat hippocampus. The results showed that intrahippocampal injections of Aβ (1-42) caused apoptosis in rat hippocampus. Oral administration of β-asarone (12.5, 25, or 50 mg/kg) for 28 d reverse the increase in the number of terminal deoxynucleotidyl transferase dUTP nick-end labeling positive cells in the hippocampus tissue. Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)-induced neuronal toxicity in AD. Therefore, we investigated nuclear translocation of apoptosis induction factors. Our results showed that β-asarone afforded a beneficial inhibition on both mRNA and protein expression of Bad, Bax, and cleavage of caspases 9 in rat hippocampus following intrahippocampal injections of Aβ (1-42). Our further investigation revealed that ASK1, p-MKK7, and p-c-Jun were significantly decreased after β-asarone treatment, implicating that the modulation of ASK1/c-JNK-mediated intracellular signaling cascades might be involved in therapeutic effect of β-asarone against Aβ toxicity. Taken together, these results suggest that β-asarone may be a potential candidate for development as a therapeutic agent for AD.<br>
Journal
-
- YAKUGAKU ZASSHI
-
YAKUGAKU ZASSHI 130 (5), 737-746, 2010-05-01
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282681103882368
-
- NII Article ID
- 130000259464
-
- NII Book ID
- AN00284903
-
- ISSN
- 13475231
- 00316903
-
- NDL BIB ID
- 10697771
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed